Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
| Clinical Trial | Principal Investigator | Related Conditions |
|---|---|---|
| MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Study Id: NCT03053193 Start Date: - End Date: |
|
|
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Study Id: NCT01042379 Start Date: - End Date: |
|
|
| I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients Study Id: NCT04488081 Start Date: - End Date: |
|
|
| Women Informed to Screen Depending on Measures of Risk (Wisdom Study) Study Id: NCT02620852 Start Date: - End Date: |
|
|
| Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS) Study Id: NCT02872025 Start Date: - End Date: |
|
|
| Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast Study Id: NCT00788112 Start Date: - End Date: |
|
|
| Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Study Id: NCT00033397 Start Date: - End Date: |
|
|
| Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer Study Id: NCT00416403 Start Date: - End Date: |
|
|
| Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction Study Id: NCT01258296 Start Date: - End Date: |
|
|
| Study of Ductal Lavage in Women at High Risk for Breast Cancer Study Id: NCT00429988 Start Date: - End Date: |
|
|
| Statins and Breast Cancer Biomarkers Study Id: NCT00914017 Start Date: - End Date: |
|